Active Ingredient: CILASTATIN SODIUM; IMIPENEM
Proprietary Name: PRIMAXIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 250MG BASE/VIAL;250MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062756
Product Number: 001
Approval Date: Jan 8, 1987
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
